Aurelian Ungureanu1,2, Magali Le Garff-Tavernier3, Myrto Costopoulos3, Timothée Parratte4, Abdelmalek Brinet4, Hélène Durand4, Claude Gaultier4, Remy Hurstel5, Isabelle Alamome5, François Sellal4, Guido Ahle4. 1. Service de Neurologie, Hôpitaux Civils de Colmar, Colmar, France. aurelianungureanu@hotmail.com. 2. Service de Neurologie, Hôpital Saint Antoine et Hôpital Pitié Salpêtrière, AP-HP, 184 Faubourg de Saint Antoine, 75012, Paris, France. aurelianungureanu@hotmail.com. 3. Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France. 4. Service de Neurologie, Hôpitaux Civils de Colmar, Colmar, France. 5. Laboratoire d'Hématologie, Hôpitaux Civils de Colmar, Colmar, France.
Abstract
BACKGROUND: Interleukin 6 (IL-6) is a pleomorphic cytokine that can be found in the cerebrospinal fluid (CSF) in a wide spectrum of inflammatory pathologies of the central nervous system (CNS). OBJECTIVE: Our aim was to characterize the diagnostic significance of CSF IL-6 among various CNS inflammatory diseases with pseudotumoral lesions (CNSID) and primary CNS lymphoma (PCNSL). METHODS: We retrospectively analyzed the CSF IL-6 concentrations in 43 consecutive patients with suspected PCNSL. A total of 28 patients were positively diagnosed with PCNSL and 15 with CNSID. We verified the results with CSF IL-10, an established biomarker for PCNSL. RESULTS: In the PCNSL group, the median CSF IL-6 concentration was 8 pg/ml, interquartile range (IQR) 5-18.5. For the patients with CNSID, the median concentration was 70 pg/ml, IQR 5-1368. A group comparison showed significantly higher CSF IL-6 levels in patients with CNSID than in those with PCNSL (p = 0.032). Moreover, IL-6 was correlated with CSF cell count in the CNSID group (r = 0.56, p = 0.028), but not in the PCNSL group (r = 0.3, p = 0.13). We found significantly higher CSF IL-10 levels in patients with PCNSL than in patients with CNS inflammatory lesions (p < 0.001). DISCUSSION AND CONCLUSIONS: Our study suggests that CSF IL-6 levels could represent, in addition to CSF IL-10, a useful biomarker in the differential diagnosis of CNSID and suspected PCNSL.
BACKGROUND: Interleukin 6 (IL-6) is a pleomorphic cytokine that can be found in the cerebrospinal fluid (CSF) in a wide spectrum of inflammatory pathologies of the central nervous system (CNS). OBJECTIVE: Our aim was to characterize the diagnostic significance of CSF IL-6 among various CNS inflammatory diseases with pseudotumoral lesions (CNSID) and primary CNS lymphoma (PCNSL). METHODS: We retrospectively analyzed the CSF IL-6 concentrations in 43 consecutive patients with suspected PCNSL. A total of 28 patients were positively diagnosed with PCNSL and 15 with CNSID. We verified the results with CSF IL-10, an established biomarker for PCNSL. RESULTS: In the PCNSL group, the median CSF IL-6 concentration was 8 pg/ml, interquartile range (IQR) 5-18.5. For the patients with CNSID, the median concentration was 70 pg/ml, IQR 5-1368. A group comparison showed significantly higher CSF IL-6 levels in patients with CNSID than in those with PCNSL (p = 0.032). Moreover, IL-6 was correlated with CSF cell count in the CNSID group (r = 0.56, p = 0.028), but not in the PCNSL group (r = 0.3, p = 0.13). We found significantly higher CSF IL-10 levels in patients with PCNSL than in patients with CNS inflammatory lesions (p < 0.001). DISCUSSION AND CONCLUSIONS: Our study suggests that CSF IL-6 levels could represent, in addition to CSF IL-10, a useful biomarker in the differential diagnosis of CNSID and suspected PCNSL.
Authors: Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo Journal: Nature Date: 2006-04-30 Impact factor: 49.962
Authors: Agnieszka Korfel; Martha Nowosielski; Javier Pardo-Moreno; Francisco Javier Penalver; Gabriele Buda; Hind Bennani; Myrto Costopoulos; Magali Le Garff-Tavernier; Carole Soussain; Mathias Schmid; Jose Alberto Orfao; Michael Glantz Journal: Expert Rev Hematol Date: 2016-10-21 Impact factor: 2.929
Authors: James L Rubenstein; Valerie S Wong; Cigall Kadoch; Hua-Xin Gao; Ramon Barajas; Lingjing Chen; S Andrew Josephson; Brian Scott; Vanja Douglas; Mekhala Maiti; Lawrence D Kaplan; Patrick A Treseler; Soonmee Cha; Jimmy H Hwang; Paola Cinque; Jason G Cyster; Clifford Lowell Journal: Blood Date: 2013-04-09 Impact factor: 22.113
Authors: Anouk van Westrhenen; Lisanne C A Smidt; Tatjana Seute; Stefan Nierkens; Abraham C J Stork; Monique C Minnema; Tom J Snijders Journal: Br J Haematol Date: 2018-05-29 Impact factor: 6.998